Company shares last traded at $81.14 which is a tad above the 50 day moving average which is $75.57 and which is impressively higher than the 200 day moving average of $72.84. The 50 day moving average moved up $5.57 whereas the 200 day moving average was up $8.30 or +11.40%. Trading volume for Cantel Medical Corp. was 0 on Wednesday. Shares saw a steep decrease in trading volume of nan% under the normal average daily volume.
These funds have shifted positions in (CMN). Susquehanna International Group, Llp added to its stake by buying 28,756 shares an increase of 1,027.0%. Susquehanna International Group, Llp owns 31,556 shares valued at $2,459,000. The value of the position overall is up by 997.8%. As of quarter end Assetmark, Inc had sold 885 shares trimming its stake by 2.7%. The value of the company’s investment in Cantel Medical Corp. decreased from $2,648,000 to $2,507,000 decreasing 5.3% quarter over quarter.
As of the end of the quarter Kimelman & Baird, LLC had disposed of a total of 124,543 shares trimming its position 35.7%. The value of the investment in CMN went from $27,926,000 to $17,459,000 a change of 37.5% for the reporting period. As of quarter end Vanguard Group Inc had bought 65,975 shares growing its holdings by 2,978.6%. The value of the investment in Cantel Medical Corp. increased from $177,000 to $5,313,000 a change of $5,136,000 quarter to quarter.